[PDF][PDF] Tumor microenvironment: extracellular matrix alterations influence tumor progression

S Brassart-Pasco, S Brézillon, B Brassart… - Frontiers in …, 2020 - frontiersin.org
The tumor microenvironment (TME) is composed of various cell types embedded in an
altered extracellular matrix (ECM). ECM not only serves as a support for tumor cell but also …

[HTML][HTML] Collagen remodeling along cancer progression providing a novel opportunity for cancer diagnosis and treatment

K Song, Z Yu, X Zu, G Li, Z Hu, Y Xue - International journal of molecular …, 2022 - mdpi.com
The extracellular matrix (ECM) is a significant factor in cancer progression. Collagens, as the
main component of the ECM, are greatly remodeled alongside cancer development. More …

[HTML][HTML] Collagen family as promising biomarkers and therapeutic targets in cancer

L Necula, L Matei, D Dragu, I Pitica, A Neagu… - International Journal of …, 2022 - mdpi.com
Despite advances in cancer detection and therapy, it has been estimated that the incidence
of cancers will increase, while the mortality rate will continue to remain high, a fact explained …

Collagen VI as a driver and disease biomarker in human fibrosis

L Williams, T Layton, N Yang, M Feldmann… - The FEBS …, 2022 - Wiley Online Library
Fibrosis of visceral organs such as the lungs, heart, kidneys and liver remains a major cause
of morbidity and mortality and is also associated with many other disorders, including cancer …

Targeting tumor-stromal interactions in pancreatic cancer: impact of collagens and mechanical traits

P Maneshi, J Mason, M Dongre… - Frontiers in Cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst outcomes among cancers
with a 5-years survival rate of below 10%. This is a result of late diagnosis and the lack of …

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300

LM Williams, FE McCann, MA Cabrita, T Layton… - Proceedings of the …, 2020 - pnas.org
Fibrotic diseases remain a major cause of morbidity and mortality, yet there are few effective
therapies. The underlying pathology of all fibrotic conditions is the activity of myofibroblasts …

Endotrophin, a key marker and driver for fibroinflammatory disease

K Henriksen, F Genovese, A Reese-Petersen… - Endocrine …, 2024 - academic.oup.com
Our overview covers several key areas related to recent results obtained for collagen type VI
and endotrophin (ETP).(1) An introduction to the history of ETP, including how it was …

[HTML][HTML] Extracellular matrix biomarkers in colorectal cancer

MS Kim, SE Ha, M Wu, H Zogg, CF Ronkon… - International journal of …, 2021 - mdpi.com
The cellular microenvironment composition and changes therein play an extremely
important role in cancer development. Changes in the extracellular matrix (ECM), which …

[HTML][HTML] Collagen biomarkers quantify fibroblast activity in vitro and predict survival in patients with pancreatic ductal adenocarcinoma

NI Nissen, AZ Johansen, I Chen, JS Johansen… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. New
tools which can aid in the understanding of PDAC biology and novel drug development are …

The biological foundations of sarcopenia: established and promising markers

M Casati, AS Costa, D Capitanio, L Ponzoni… - Frontiers in …, 2019 - frontiersin.org
Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health
issues in older adults, given its high prevalence accompanied by huge clinical and …